Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach
In survival analysis, patients on peritoneal dialysis are confronted with three different outcomes: transfer to hemodialysis, renal transplantation, or death. The Kaplan-Meier method takes into account one event only, so whether it adequately considers these different risks is questionable. The more recent competing risks method has been shown to be more appropriate in analyzing such situations.
We compared the estimations obtained by the Kaplan-Meier method and the competing risks method (namely the Kalbfleisch and Prentice approach), in 383 consecutive incident peritoneal dialysis patients. By means of simulations, we then compared the Kaplan-Meier estimations obtained in two virtual centers where patients had exactly the same probability of death. The only difference between these two virtual centers was whether renal transplantation was available or not.
At five years, 107 (27.9%) patients had died, 109 (28.4%) had been transferred to hemodialysis, 91 (23.8%) had been transplanted, and 37 (9.7%) were still alive on peritoneal dialysis; before five years, 39 (10.2%) patients were censored alive on peritoneal dialysis. The five-year probabilities estimated by the Kaplan-Meier and the competing risks methods were respectively: death: 50% versus 30%; transfer to hemodialysis: 59% versus 32%; renal transplantation: 39% versus 26%; event-free survival: 12% versus 12%. The sum of the Kaplan-Meier estimations exceeded 100%, implying that patients could experience more than one event, death and transplantation for example, which is impossible. In the simulations, the probability of death estimated by the Kaplan-Meier method increased as the probability of renal transplantation increased, although the probability of death actually remained constant.
The competing risks method appears more appropriate than the Kaplan-Meier method for estimating the probability of events in peritoneal dialysis in the context of univariable survival analysis.
- Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010, 21:499–506. CrossRef
- McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR: Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009, 20:155–163. CrossRef
- Gooley TA, Leisenring W, Crowley J, Storer BE: Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695–706. CrossRef
- Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. 2nd edition. New York: Wiley Interscience; 2002. CrossRef
- Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002, 13:1307–1320.
- Evans DW, Ryckelynck J-P, Fabre E, Verger C: Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account. Nephrol Dial Transplant 2010, 25:2315–2322. CrossRef
- Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007, 26:2389–2430. CrossRef
- Tai BC, Machin D, White I, Gebski V: Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med 2001, 20:661–684. CrossRef
- Kim HT: Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007, 13:559–565. CrossRef
- Sobolev BG, Levy AR, Kuramoto L, Hayden R, Brophy JM, FitzGerald JM: The risk of death associated with delayed coronary artery bypass surgery. BMC Health Serv Res 2006, 6:85. CrossRef
- Smits JM, van Houwelingen HC, De Meester J, Persijn GG, Claas FH: Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation 1998, 66:1146–1153. CrossRef
- Couchoud C, Stengel B, Landais P, Aldigier J-C, de Cornelissen F, Dabot C, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C: The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006, 21:411–418. CrossRef
- Pocock SJ, Clayton TC, Altman DG: Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002, 359:1686–1689. CrossRef
- Bender R, Augustin T, Blettner M: Generating survival times to simulate Cox proportional hazards models. Stat Med 2005, 24:1713–1723. CrossRef
- Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, Itami N, Ogata S, Kimata N, Shinoda T, Syouji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Fujii N, Marubayashi S, Morita O, Wakai K, Wada A, Iseki K, Tsubakihara Y: An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial 2009, 13:457–504. CrossRef
- Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725–1730. CrossRef
- Satayathum S, Pisoni RL, McCullough KP, Merion RM, Wikström B, Levin N, Chen K, Wolfe RA, Goodkin DA, Piera L, Asano Y, Kurokawa K, Fukuhara S, Held PJ, Port FK: Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2005, 68:330–337. CrossRef
- Stel VS, van Dijk PCW, van Manen JG, Dekker FW, Ansell D, Conte F, Kramar R, Leivestad T, Vela E, Briggs JD, Jager KJ: Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005, 20:2803–2811. CrossRef
- Couchoud C, Lassalle M, Stengel B, Jacquelinet C: Renal Epidemiology and Information Network: 2007 annual report. Nephrol Ther 2009,5(Suppl 1):S3-S144.
- Kleinbaum DG, Klein M: Competing Risks Survival Analysis. In Survival Analysis, a Self-Learning Text. New-york: Springer Science + Business media Inc; 2005:391–461.
- Bayat S, Kessler M, Briançon S, Frimat L: Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly. Nephrol Dial Transplant 2010, 25:292–300. CrossRef
- Garg PP, Frick KD, Diener-West M, Powe NR: Effect of the ownership of dialysis facilities on patients’ survival and referral for transplantation. N Engl J Med 1999, 341:1653–1660. CrossRef
- Robins JM, Finkelstein DM: Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000, 56:779–788. CrossRef
- Schaubel DE, Wei G: Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring. Biometrics 2011, 67:29–38. CrossRef
- Van Biesen W, Vanholder R, Debacquer D, De Backer G, Lameire N: Comparison of survival on CAPD and haemodialysis: statistical pitfalls. Nephrol Dial Transplant 2000, 15:307–311. CrossRef
- Vonesh EF, Schaubel DE, Hao W, Collins AJ: Statistical methods for comparing mortality among ESRD patients: examples of regional/international variations. Kidney Int 2000, 57:S19-S27. CrossRef
- Chung SH, Heimbürger O, Lindholm B, Lee HB: Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 2005, 20:1207–1213. CrossRef
- Davies SJ, Phillips L, Russell GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998, 13:962–968. CrossRef
- Reyes M-JF, Bajo M-A, Hevía C, Del Peso G, Ros S, de Miguel AG, Cirugeda A, Castro M-J, Sánchez-Tomero JA, Selgas R: Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance. Nephrol Dial Transplant 2007, 22:218–223. CrossRef
- Knol AB, Slottje P, van der Sluijs JP, Lebret E: The use of expert elicitation in environmental health impact assessment: a seven step procedure. Environ Health 2010, 9:19. CrossRef
- Klein JP, Rizzo JD, Zhang MJ, Keiding N: Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant 2001, 28:909–915. CrossRef
- Klein JP, Rizzo JD, Zhang MJ, Keiding N: Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant 2001, 28:1001–1011. CrossRef
- Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C: Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 2005, 16:2449–2455. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/13/31/prepub
- Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Online Date
- May 2012
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. Research Department, CERIM, EA 2694, Faculty of Medicine, 1 Place Verdun, F-59045, Lille, CEDEX, France
- 2. University of Lille, Lille, France
- 3. Department of Biostatistics, EA2694, UDSL, Lille, France
- 4. Nephrology Department, CHU, Lille, France
- 5. Nephrology Department, EA 4003, INSERM CIC-EC CIE6, Nancy University, Nancy, France